EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Quantitative Systems Pharmacology Modeling in Immuno-Oncology: Hypothesis Testing, Dose Optimization, and Efficacy Prediction

Hanwen Wang, Theinmozhi Arulraj, Alberto Ippolito, Aleksander S Popel

Handbook of Experimental Pharmacology · 2024 · 261-284

DOI: 10.1007/164_2024_735 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Handbook of Experimental Pharmacology, online erschienen am 21.12.2024. Verfasst von Hanwen Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Network Pharmacology, Models, Biological. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite an increasing number of clinical trials, cancer is one of the leading causes of death worldwide in the past decade. Among all complex diseases, clinical trials in oncology have among the lowest success rates, in part due to the high intra- and inter-tumoral heterogeneity. There are more than a thousand cancer drugs and treatment combinations being investigated in ongoing clinical trials for various cancer subtypes, germline mutations, metastasis, etc. Particularly, treatments relying on the (re)activation of the immune system have become increasingly present in the clinical trial pipeline. However, the complexities of the immune response and cancer-immune interactions pose a challenge to the development of these therapies. Quantitative systems pharmacology (QSP), as a computational approach to predict tumor response to treatments of interest, can be used to conduct in silico clinical trials with virtual patients (and emergent use of digital twins) in place of real patients, thus lowering the time and cost of clinical trials. In line with improved mechanistic understanding of the human immune system and promising results from recent cancer immunotherapy, QSP models can play critical roles in model-informed drug development in immuno-oncology. In this chapter, we discuss how QSP models were designed to serve different study objectives, including hypothesis testing, dose optimization, and efficacy prediction, via case studies in immuno-oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyNetwork PharmacologyModels, BiologicalAntineoplastic AgentsHumansAnimalsDose-Response Relationship, Drug

Stichwörter der Autor:innen

Cancer immunotherapyClinical trial simulationCytokine release syndromeMechanistic modelingT cell engager

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. apopel@jhu.edu.
  • Department of Oncology, and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. apopel@jhu.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wang, H., Arulraj, T., Ippolito, A., & Popel, A. S. (2024). Quantitative Systems Pharmacology Modeling in Immuno-Oncology: Hypothesis Testing, Dose Optimization, and Efficacy Prediction. Handbook of Experimental Pharmacology, 261-284. https://doi.org/10.1007/164_2024_735

Vancouver

Wang H, Arulraj T, Ippolito A, Popel AS. Quantitative Systems Pharmacology Modeling in Immuno-Oncology: Hypothesis Testing, Dose Optimization, and Efficacy Prediction. Handbook of Experimental Pharmacology. 2024:261-284. doi:10.1007/164_2024_735

BibTeX
@article{Wang2024,
  author = {Wang, Hanwen and Arulraj, Theinmozhi and Ippolito, Alberto and Popel, Aleksander S},
  title = {Quantitative Systems Pharmacology Modeling in Immuno-Oncology: Hypothesis Testing, Dose Optimization, and Efficacy Prediction},
  journal = {Handbook of Experimental Pharmacology},
  year = {2024},
  pages = {261--284},
  doi = {10.1007/164_2024_735}
}
Kostenlos starten →